Compare Inovio Pharmaceuticals Inc (INO) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Stitch Fix Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while Stitch Fix Inc trades at $3.53 (market cap $497.68M). The key difference: Stitch Fix Inc is far larger — about 6.3× Inovio Pharmaceuticals Inc's market cap, and Stitch Fix Inc is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | SFIX | |
|---|---|---|
Market Cap | $78.55M | $497.68M |
Sector | Health | Consumer Cyclical |
52-Week High | $2.87 | $5.83 |
52-Week Low | $0.66 | $3.06 |
Enterprise Value | $49.56M | $385.40M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INO trades at $0.76, up 2.74% today, but remains in a bearish technical trend. The company shows minimal revenue of $65K against high operating losses, with a net income margin of -130,000%. Recent quarterly EPS has beaten expectations. Analyst consensus is bullish with a $3.25 price target, but the stock faces significant fundamental challenges including negative cash flow and high valuation multiples.
The outlook hinges on FDA approval of INO-3107 in October 2026, a binary event that could drive substantial upside. However, persistent cash burn, negative profitability, and ongoing shareholder litigation present high risks. Investors should weigh the potential catalyst against the company's weak financial health and operational execution challenges.
Stitch Fix (SFIX) trades at $3.565, down 10.2% in the past day, reflecting recent volatility. The stock shows a bullish technical signal with improving earnings trends, as recent quarters beat EPS estimates. Revenue stabilized at $1.27B in 2025, with net losses narrowing to -$28.74M, indicating progress toward profitability. News highlights AI-driven personalization efforts and new executive appointments aimed at growth.
The outlook suggests a turnaround opportunity, supported by a low P/S ratio of 0.37 and a consensus price target of $4.75 (33% upside). Risks include persistent net losses, competitive pressures, and consumer spending sensitivity. Analysts are mixed, with 27% buy ratings, but improving cash flow and debt-free balance sheet provide stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
